Search Results 101-110 of 14688 for anti-TNF drugs

  1. Tofacitinib (Oral Route) Description and Brand Names - Mayo Clinic

    Tofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ...

  2. NSAIDs: Do they increase my risk of heart attack and stroke? - Mayo Clinic

    Yes. Nonsteroidal anti-inflammatory drugs (NSAIDs) can increase the risk of heart attack and stroke. These medicines most often treat pain, swelling and ...

  3. Publications - Lynne S. Peterson, M.D. - Mayo Clinic

    ... anti-TNF therapy (poster presentation). European League Against Rheumatism (EULAR).2004;; Peterson LS, Mason T, Mason T, Nelson AM, O'Fallon WM, Gabriel SE ...

  4. Flurbiprofen (Oral Route) Description and Brand Names - Mayo Clinic

    Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) used to relieve symptoms of arthritis (osteoarthritis and rheumatoid arthritis), such as ...

  5. Prednisone and other corticosteroids: Balance the risks and benefits - Mayo Clinic

    Corticosteroid medicines include cortisone, hydrocortisone and prednisone. They are useful in treating rashes, inflammatory bowel disease, asthma and other ...

  6. Pain medicines after surgery - Mayo Clinic

    Other medicines that can treat pain after surgery include the anti-anxiety medicine midazolam and the anti-seizure medicines gabapentin (Gralise, Horizant, ...

  7. How obesity affects IBD management and patient outcomes: Q&A with Amanda M. Johnson, M.D. - Mayo Clinic

    Related Content. Article. Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Article. Research establishes ...

  8. centers-of-excellence

    Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy - Mayo Clinic. Overview Tab Title ...

  9. Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects with Moderate to Severe Crohn's Disease - Mayo Clinic

    This study will evaluate the efficacy and safety of two adalimumab induction regimens in subjects with moderately to severely active Crohn's disease and ...

  10. Clinical Trials - Mayo Clinic Research

    ... Anti-TNF Therapy (COMBINE) Low Dose Oral Methotrexate in Pediatric Crohn's Disease Patients Initiating Anti-Tumor Necrosis Factor (Anti-TNF) Therapy NCT ID ...